Literature DB >> 10875954

Evaluation of intensive inpatient treatment of patients with severe personality disorders.

G O Gabbard1, L Coyne, J G Allen, H Spohn, D B Colson, M Vary.   

Abstract

OBJECTIVE: The purpose of this study was to determine whether severe personality disorders improve or deteriorate with intensive inpatient treatment.
METHODS: Overall 216 patients diagnosed as having personality disorders by DSM-III-R criteria were prospectively monitored at two private psychiatric hospitals from admission through discharge to one-year follow-up.
RESULTS: Substantial positive change in the sample was recorded at discharge, and the improvements held up at one-year follow-up. The proportion of patients with scores of 50 or more on the Global Assessment Scale was 3.7 percent at the time of admission. By discharge the proportion had increased to 55.1 percent, and by one-year follow-up it had risen to 66.3 percent.
CONCLUSIONS: These results suggest that patients with severe personality disorders benefit from intensive inpatient treatment. We found no evidence that hospitalization of such patients is associated with regression or deterioration of function.

Entities:  

Mesh:

Year:  2000        PMID: 10875954     DOI: 10.1176/appi.ps.51.7.893

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  3 in total

1.  DOES HAVING A DYSFUNCTIONAL PERSONALITY HURT YOUR CAREER? AXIS II PERSONALITY DISORDERS AND LABOR MARKET OUTCOMES.

Authors:  Susan L Ettner; Johanna Catherine Maclean; Michael T French
Journal:  Ind Relat (Berkeley)       Date:  2011-01

Review 2.  Psychological therapies for people with borderline personality disorder.

Authors:  Jutta M Stoffers; Birgit A Völlm; Gerta Rücker; Antje Timmer; Nick Huband; Klaus Lieb
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

3.  Comparison of treatment outcomes in severe personality disorder patients with or without substance use disorders: a 36-month prospective pragmatic follow-up study.

Authors:  Fernando Lana; Carmen Sánchez-Gil; Núria D Adroher; Víctor Pérez; Guillem Feixas; Josep Martí-Bonany; Marta Torrens
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-21       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.